Codexis to Present at 2013 UBS Global Healthcare Conference
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Codexis, Inc. (NAS: CDXS) , a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 2013 UBS Global Healthcare Conference on Monday, May 20, 2013 at 3:00 p.m. ET in New York City.
A live webcast and replay will be available on the Investors section of the company's website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical production. Codexis' proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development - from research to manufacturing. For more information, see www.codexis.com.
KEYWORDS: United States North America California New York
The article Codexis to Present at 2013 UBS Global Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.